Notable Surge In Buprenorphine Prescriptions Propels Visceral Pain Market Expansion: A Key Factor Shaping the Future of the Visceral Pain Market in 2025

What Are the Projections for the Size and Growth Rate of the Visceral Pain Market?
Over the past few years, significant expansion has occurred in the visceral pain market. The projection is for it to escalate from a value of $13.84 billion in 2024 to a value of $14.87 billion in 2025, a compound annual growth rate (CAGR) of 7.5%. The surge during the historical growth cycle has been driven by factors such as an older population, a surge in chronic illnesses, innovations in medical research, better healthcare facilities, and an upswing in awareness as well as diagnosis rates.

The market for visceral pain is anticipated to significantly expand in the upcoming years, predicted to hit a value of $18.71 billion in 2029, with a CAGR of 5.9%. The projected growth during this period is due to advancements in pain management technology, increasing preference for non-invasive treatments, emerging markets combined with untouched potential, tailored medical treatments, and the inclusion of digital health solutions. The period's key trends will be a move towards multimodal pain management, a heightened focus on alternative therapies, the upsurge of targeted therapies for distinct pain classifications, greater reliance on telemedicine for pain management, and the merging of artificial intelligence with pain evaluation.

What Are the Main Catalysts for Growth in the Visceral Pain Market?
The escalating need for pain relievers, also known as analgesics, is anticipated to propel the visceral pain market's expansion in the future. These analgesics function by reducing or obstructing pain receptors in the brain, thereby alleviating pain. They aid in controlling visceral pain by focusing on the nervous system and moderating pain signals from the internal organs. For example, the New England Journal of Medicine, a weekly medical journal based in the UK, reported in April 2024 that more than 53,600 clinicians had been prescribing buprenorphine by December 2023. This indicates a surge of 11,500 prescribers from December 2022. Consequently, the growing demand for analgesics is steering the growth of the visceral pain market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13950&type=smp

Which Businesses Are at the Forefront of Visceral Pain Market Development?
Major companies operating in the visceral pain market report are Walgreens Boots Alliance Inc., Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co.Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Endo International PLC, Grünenthal GmbH, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co. Ltd., Chromocell Corporation, Addex Therapeutics Ltd.

What Are the Latest Innovations in the Visceral Pain Market?
Noteworthy companies within the visceral pain market are progressing with the invention of unique products like NHE3 Inhibitor, aiming to offer trustworthy services to their consumers. NHE3 inhibitors fall under the category of drugs that function by impeding the Sodium-Proton-Exchanger subtype 3 (NHE3) within the digestive system. For example, in April 2022, a biopharmaceutical company based in the US, Ardelyx, unveiled their NHE3 Inhibitor drug called IBSRELA. IBSRELA serves as an innovative form of treatment for adult individuals suffering from irritable bowel syndrome accompanied by constipation (IBS-C). It operates by hindering the Sodium-Hydrogen Exchanger 3 (NHE3) within the tiny intestine and the colon. In vivo studies have demonstrated its capacity to lessen abdominal pain by reducing visceral hypersensitivity and enhancing intestinal permeability.

How Is the Visceral Pain Market Segmented?
The visceral pain market covered in this report is segmented -

1) By Drug Class: Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes
2) By Indications: Interstitial Cystitis, Crohn's, Irritable Bowel, Chronic Prostatitis, Other Indications
3) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:
1) By Calcium Channel Blockers: Dihydropyridines, Non-Dihydropyridines
2) By Nonsteroidal Anti-Inflammatory Drugs (NSAID): Selective COX-2 Inhibitors, Non-Selective NSAIDs
3) By Other Drug Classes: Opioids, Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/visceral-pain-global-market-report

Where Is the Visceral Pain Market Growth Most Prominent?
North America was the largest region in the visceral pain market in 2024. The regions covered in the visceral pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Visceral Pain Global Market Report?

- Market Size Analysis: Analyze the Visceral Pain Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Visceral Pain Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Visceral Pain Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Visceral Pain Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13950

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.